Novo Nordisk CFO Knudsen: Oral Wegovy Drives Market Expansion With 80% of Patients New to Obesity Drugs — BigGo Finance
Novo Nordisk delivered what CFO Karsten Munk Knudsen called “one of the bigger guidance hikes we’ve had as…
Browsing Tag